In this issue of Cardiology Clinics, guest editors Drs. Silvi Shah and Janani Rangaswami bring their considerable expertise to the topic of Cardio-Kidney-Metabolic Disorder. Top experts discuss key topics such as definition, staging, risk assessment, and therapeutic considerations; sex difference in CVD with kidney disease; obesity and CKM health: ethnicity-based risk and clinical considerations; SGLT2i across the spectrum of CKM health; and more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations - p. 337 9. Nonatherosclerotic Cardiovascular Disease in Chronic Kidney Disease - p. 359 10. Sex Differences in Cardiovascular Diseases and Vascular Function in Chronic Kidney Disease - p. 371 11. Obesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical Considerations - p. 383 12. Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome - p. 403 13. Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions - p. 415 14. Atherosclerotic Cardiovascular Disease in Cardiovascular–Kidney-Metabolic Syndrome - p. 433 15. Kidney Transplant and Cardiovascular-Kidney-Metabolic Health - p. 441 16. Long-Term Cardio-Renal-Metabolic Complications Following Pre-eclampsia - p. 457 17. A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome - p. 469 18. Cardio-Kidney Metabolic Health in Pediatrics and Primordial Prevention - p. 481 19. History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease - p. 491
In this issue of Cardiology Clinics, guest editors Drs. Silvi Shah and Janani Rangaswami bring their considerable expertise to the topic of Cardio-Kidney-Metabolic Disorder. Top experts discuss key topics such as definition, staging, risk assessment, and therapeutic considerations; sex difference in CVD with kidney disease; obesity and CKM health: ethnicity-based risk and clinical considerations; SGLT2i across the spectrum of CKM health; and more.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. x 7. Preface - p. xi 8. Cardiovascular-Kidney-Metabolic Health: Definition, Staging, Risk Assessment, and Therapeutic Considerations - p. 337 9. Nonatherosclerotic Cardiovascular Disease in Chronic Kidney Disease - p. 359 10. Sex Differences in Cardiovascular Diseases and Vascular Function in Chronic Kidney Disease - p. 371 11. Obesity and Cardiovascular-Kidney-Metabolic Health: Ethnicity-Based Risk and Clinical Considerations - p. 383 12. Sodium Glucose Cotransporter 2 Inhibitors Across the Spectrum of Cardiovascular Kidney Metabolic Syndrome - p. 403 13. Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions - p. 415 14. Atherosclerotic Cardiovascular Disease in Cardiovascular–Kidney-Metabolic Syndrome - p. 433 15. Kidney Transplant and Cardiovascular-Kidney-Metabolic Health - p. 441 16. Long-Term Cardio-Renal-Metabolic Complications Following Pre-eclampsia - p. 457 17. A Plant-Based Diet for Cardiovascular Risk Reduction in Kidney Disease with a Focus on Cardiovascular-Kidney-Metabolic Syndrome - p. 469 18. Cardio-Kidney Metabolic Health in Pediatrics and Primordial Prevention - p. 481 19. History and Evolution of Hypertension Goals in Patients with Chronic Kidney Disease - p. 491
